NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update
Provided By GlobeNewswire
Last update: Aug 19, 2025
CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Aug. 19, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi–Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, today announced financial results for the quarter ended June 30, 2025, and provided an update on recent operational achievements and upcoming milestones.
Read more at globenewswire.com
